
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Let's start taking "e" for granted and look instead at the features we really need in clinical technology applications.
over 25 years ago
Public Key Infrastructure: The Beginning of a Beautiful Friendship?over 25 years ago
Ethics, Kids, and Sexover 25 years ago
Clinical Research Training on the Webover 25 years ago
The EMEA Keeps Up-to-Dateover 25 years ago
The Virtual Organization: Is It the Future Industry Landscape?over 25 years ago
Letters to the Editorover 25 years ago
Do You "Go the Extra Mile" or Adopt a Minimalist Mindsetover 25 years ago
David Sabrittover 25 years ago
The Virtual Organization





